Consistent Export Growth: 3.92% CAGR Over 7 Years
India's exports under HSN Sub-Chapter 3003 have grown at a compound annual rate of 3.92% over 7 fiscal years, rising from ₹2,183.45 Crore in FY 2018-19 to ₹2,750.49 Crore in FY 2024-25.
HSN Sub Chapter 3003 represents Mixed medicaments, therapeutic use under GST classification. This code helps businesses identify Mixed medicaments, therapeutic use correctly for billing, taxation, and trade purposes. With HSN Sub Chapter 3003, companies can avoid errors in invoices, simplify compliance, and enable hassle-free import/export of Mixed medicaments, therapeutic use.
Join our guided walkthrough to see how BUSY can transform your business operations.
GST Rate for Mixed medicaments, therapeutic use under HSN Code 3003. Understand current tax rates, exemptions, and legal classifications to ensure accurate billing and GST filing.
Chapter No
30HSN Code
HSN Description
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale
New GST Rate
Old GST Rate
Following tariff HSN codes fall under Mixed medicaments, therapeutic use.
Tariff HSN
Description
Containing penicillins or derivatives thereof, with a penicillanic acid structure, or streptomycins or their derivatives
Tariff HSN
Description
Containing other antibiotics
Tariff HSN
Description
Containing hormones or other products of heading 2937 but not containing antibiotics : Containing insulin
Tariff HSN
Description
Containing hormones or other products of heading 2937 but not containing antibiotics : Other
Tariff HSN
Description
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale containing alkaloids or derivatives thereof but not containing hormones or other products of heading 2937 or antibiotics
Tariff HSN
Description
Other, containing alkaloids or derivatives thereof: Containing ephedrine or its salts
Tariff HSN
Description
Other, containing alkaloids or derivatives thereof: Containing pseudoephedrine (INN) or its salts
Tariff HSN
Description
Other, containing alkaloids or derivatives thereof: Containing norephedrine or its salts
Tariff HSN
Description
Other, containing alkaloids or derivatives thereof: Other
Tariff HSN
Description
Other, containing antimalarial active principles described in Sub-heading Note 2 to this Chapter
Tariff HSN
Description
Other : Ayurvedic, Unani, Siddha, Homoeopathic or Bio-chemic systems medicaments : Of Ayurvedic system
Tariff HSN
Description
Other : Ayurvedic, Unani, Siddha, Homoeopathic or Bio-chemic systems medicaments : Of Unani system
Tariff HSN
Description
Other : Ayurvedic, Unani, Siddha, Homoeopathic or Bio-chemic systems medicaments : Of Siddha system
Tariff HSN
Description
Other : Ayurvedic, Unani, Siddha, Homoeopathic or Bio-chemic systems medicaments : Of Homoeopathic system
Tariff HSN
Description
Other : Ayurvedic, Unani, Siddha, Homoeopathic or Bio-chemic systems medicaments : Of Bio-chemic system
Tariff HSN
Description
Other : – Menthol crystals and milk of magnesia : Menthol crystals
Tariff HSN
Description
Other : – Menthol crystals and milk of magnesia : Milk of magnesia
Tariff HSN
Description
Other : Bovine albumin and drugs of animal origin, merbromine national formulary XII (mercurochrome), calcium sennoside, anaesthetic agents used in human or veterinary medicine or surgery, aluminium hydroxide gel : Bovine albumin and drugs of animal origin
Tariff HSN
Description
Other : Bovine albumin and drugs of animal origin, merbromine national formulary XII (mercurochrome), calcium sennoside, anaesthetic agents used in human or veterinary medicine or surgery, aluminium hydroxide gel : Merbromine national formulary XII (mercurochrome)
Tariff HSN
Description
Other : Bovine albumin and drugs of animal origin, merbromine national formulary XII (mercurochrome), calcium sennoside, anaesthetic agents used in human or veterinary medicine or surgery, aluminium hydroxide gel : Calcium sennoside
Tariff HSN
Description
Other : Bovine albumin and drugs of animal origin, merbromine national formulary XII (mercurochrome), calcium sennoside, anaesthetic agents used in human or veterinary medicine or surgery, aluminium hydroxide gel : – Anaesthetic agents used in human or veterinary medicine or surgery
Tariff HSN
Description
Other : Bovine albumin and drugs of animal origin, merbromine national formulary XII (mercurochrome), calcium sennoside, anaesthetic agents used in human or veterinary medicine or surgery, aluminium hydroxide gel : Aluminium hydroxide gel
Tariff HSN
Description
Other : Bovine albumin and drugs of animal origin, merbromine national formulary XII (mercurochrome), calcium sennoside, anaesthetic agents used in human or veterinary medicine or surgery, aluminium hydroxide gel : Ketamine
Tariff HSN
Description
Other : Other
India’s Exports
FY 2024-25₹2,750 Cr
0.0743% of India’s total exports
India’s Imports
FY 2024-25₹961 Cr
0.0158% of India’s total imports
Trade Balance
FY 2024-25₹1,789 Cr
Surplus rank #140 of 1233 subchapters
% of Chapter 30
FY 2024-251.32%
Share of Chapter 30’s total exports in FY 2024-25
Import side: 3.81% of Chapter 30’s imports
Rank Within Chapter 30
FY 2024-25#3 of 6
Position by export value among subchapters in Chapter 30
Import-side rank: #4 of 6
At a glance
3.92%
Export CAGR
FY 2018-19 → FY 2024-25 · 7 fiscal years
#212
National Export Rank
of 1233 subchapters by export value, FY 2024-25
+19.88%
Peak Growth Year
FY 2021-22 · strongest single-year move
1.32%
Contribution to Ch. 30
Share of Chapter 30 exports in FY 2024-25
7-year export and import data, FY 2018-19 to FY 2024-25, in ₹ Crore. Source: Ministry of Commerce & Industry, TradeStat EIDB.
Balance
+1,685.59
Exports
2,183.45 ₹ Cr
0.0951% share
— YoY
2.11% of Ch. 30
Imports
497.86 ₹ Cr
0.0139% share
— YoY
3.41% of Ch. 30
Balance
+1,744.18
Exports
2,229.08 ₹ Cr
0.1009% share
+2.09% YoY
1.93% of Ch. 30
Imports
484.90 ₹ Cr
0.0145% share
−2.60% YoY
2.93% of Ch. 30
Balance
+2,120.49
Exports
2,635.32 ₹ Cr
0.1225% share
+18.22% YoY
1.83% of Ch. 30
Imports
514.83 ₹ Cr
0.0177% share
+6.17% YoY
2.72% of Ch. 30
Balance
+2,136.61
Exports
3,159.26 ₹ Cr
0.1007% share
+19.88% YoY
2.19% of Ch. 30
Imports
1,022.65 ₹ Cr
0.0224% share
+98.64% YoY
3.99% of Ch. 30
Balance
+2,212.08
Exports
3,092.53 ₹ Cr
0.0854% share
−2.11% YoY
1.94% of Ch. 30
Imports
880.45 ₹ Cr
0.0153% share
−13.91% YoY
4.19% of Ch. 30
Balance
+2,030.42
Exports
2,923.87 ₹ Cr
0.0808% share
−5.45% YoY
1.60% of Ch. 30
Imports
893.45 ₹ Cr
0.0159% share
+1.48% YoY
4.17% of Ch. 30
Balance
+1,789.02
Exports
2,750.49 ₹ Cr
0.0743% share
−5.93% YoY
1.32% of Ch. 30
Imports
961.47 ₹ Cr
0.0158% share
+7.61% YoY
3.81% of Ch. 30
CAGR · 7-Year
Exports
3.92% /yr
Imports
11.59% /yr
reference, FY 2024-25
Export
₹2,08,128.62 Cr
Import
₹25,224.54 Cr
Trade Balance
+1,82,904.08
India's exports under HSN Sub-Chapter 3003 have grown at a compound annual rate of 3.92% over 7 fiscal years, rising from ₹2,183.45 Crore in FY 2018-19 to ₹2,750.49 Crore in FY 2024-25.
In FY 2024-25, HSN Sub-Chapter 3003 ranks #212 out of 1233 subchapters by total export value. Within Chapter 30, it ranks #3 of 6. By trade surplus, it ranks #140 of 1233.
The strongest single-year export movement for HSN Sub-Chapter 3003 was recorded in FY 2021-22, when exports surged by 19.88% over the prior year.
In FY 2024-25, India's exports of ₹2,750.49 Cr exceeded imports of ₹961.47 Cr, resulting in a trade surplus of ₹1,789.02 Crore — ranking #140 of 1233 by surplus magnitude.
India's imports under HSN Sub-Chapter 3003 have grown at 11.59% CAGR, reaching ₹961.47 Crore in FY 2024-25.
Among the 6 subchapters under Chapter 30, HSN Sub-Chapter 3003 ranks #3 by export value — accounting for 1.32% of the chapter's total exports in FY 2024-25. On the import side, it holds 3.81% share (rank #4).
BUSY auto-applies the correct HSN codes & GST rates, ensuring 100% error-free billing every single time.
Clear answers to common queries about HSN Sub Chapter 3003 and GST compliance.
It includes Mixed medicaments, therapeutic use
If replacement is without consideration under a pre‑agreed warranty, issue a delivery challan and reference the original invoice/contract. If consideration is charged, raise a tax invoice. Keep serial/lot details for traceability.
Ensure registration requirements are met and reconcile the operator’s TCS statements with your GSTR‑2B/3B. Map SKU descriptions to HSN to reduce mismatches and returns.
If your outward supply of Mixed medicaments, therapeutic use is taxable, ITC is generally available (Sections 16–17) except blocked credits (e.g., personal use, motor vehicles in most cases). For exempt supplies, proportionate reversal is required under Rule 42/43.
Prefer separate lines per item with its HSN so each component follows its own tax treatment. If it is a naturally bundled supply, identify the principal supply and tax the whole bundle accordingly.
Generate an e‑way bill when the consignment value exceeds ₹50,000, unless exempted for the transaction. E‑invoicing depends on turnover (AATO threshold as notified) for B2B supplies, not on the item itself.